{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:23:46Z","timestamp":1761171826220,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.farma.2010.02.002","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T04:41:10Z","timestamp":1278564070000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluaci\u00f3n de lenalidomida en el tratamiento del mieloma m\u00faltiple, la mielofibrosis y el s\u00edndrome mielodispl\u00e1sico"],"prefix":"10.1016","volume":"34","author":[{"given":"C.","family":"Hern\u00e1ndez Prats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Romero Iborra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Arroyo Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Castillo Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Real Panisello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"S\u00e1nchez Casado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2010.02.002_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157489207780832478","article-title":"Thalidomide analogues as anticancer drugs","volume":"2","author":"Aragon-Ching","year":"2007","journal-title":"Recent Patents Drug Discov"},{"key":"10.1016\/j.farma.2010.02.002_bib2","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2007.15.2546","article-title":"Individualizing treatment of patients with myeloma in the era of novel agents","volume":"26","author":"San Miguel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.farma.2010.02.002_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.blre.2008.07.003","article-title":"Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma","volume":"23","author":"Palumbo","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.farma.2010.02.002_bib4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2215\/CJN.03060906","article-title":"Multiple myeloma","volume":"1","author":"Singhal","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.farma.2010.02.002_bib5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2141.1996.d01-1891.x","article-title":"Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma","volume":"95","author":"Govindarajan","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.farma.2010.02.002_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198405243102104","article-title":"Effective treatment of advanced multiple myeloma refractory to alkylating agents","volume":"310","author":"Barlogie","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.farma.2010.02.002_bib7","first-page":"160","article-title":"Evaluating oral lenalidomide and dexamethasone versus placebo and dexamethasone in patients with relapsed or refractory multiple myeloma","volume":"90","author":"Dimopoulos","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.farma.2010.02.002_bib8","doi-asserted-by":"crossref","first-page":"239a","DOI":"10.1182\/blood.V108.11.798.798","article-title":"Lenalidomide plus dexamethasone in newly diagnosed myeloma: Response to therapy, time to progression, and survival (abstract)","volume":"108","author":"Lacy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.farma.2010.02.002_bib9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.farma.2010.02.002_bib10","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","article-title":"Long-term outcome of 231 patients with essential thrombocythemia: Prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia","volume":"165","author":"Chim","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.farma.2010.02.002_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1200\/JCO.2004.08.160","article-title":"Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial","volume":"22","author":"Marchetti","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.farma.2010.02.002_bib12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"enalidomide in the myelodysplastic s\u00edndrome with chromosome 5 q deletion","volume":"355","author":"List","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.farma.2010.02.002_bib13","unstructured":"FDA Approval for Lenalidomide [consultado 2\/2008]. Disponible en: http:\/\/www.cancer.gov\/cancertopics\/druginfo\/fda_lenalidomide"},{"key":"10.1016\/j.farma.2010.02.002_bib14","first-page":"301","article-title":"Multiple myeloma: Charging toward a bright future","volume":"57","author":"Katzel","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.farma.2010.02.002_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2141.2007.06538.x","article-title":"Lenalidomide in combination with cyclophosphamide and dexamethasone, is an effective and tolerated regimenfor myeloma patients","volume":"137","author":"Morgan","year":"2007","journal-title":"Br J Haematol"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063431000142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113063431000142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:15:10Z","timestamp":1761106510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S113063431000142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S113063431000142X"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2010.02.002","relation":{},"ISSN":["1130-6343"],"issn-type":[{"type":"print","value":"1130-6343"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluaci\u00f3n de lenalidomida en el tratamiento del mieloma m\u00faltiple, la mielofibrosis y el s\u00edndrome mielodispl\u00e1sico","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2010.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 SEFH. Published by Elsevier Espa\u00f1a S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}